The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial

Clinical trial NCT00095654 · COMPLETED

Trial details

NCT number: NCT00095654
Sponsor: Gerstein, Hertzel, MD
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Impaired Glucose Tolerance Cardiovascular Disease Glucose Metabolism Disorders

Start date: 2001-07-01
Enrollment: 5000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.